Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > We can forget SVA listing on Nasdaq

<< Previous

Bullboard Posts

Next >>

Post by steadfaston Dec 13, 2020 2:27pm

201 Views

Post# 32096029

We can forget SVA listing on Nasdaq

SVA do not meet any of the 4 Standard Requirements. Mgt must concentrate on
getting an IR firm that can get the share price to equal a mkt cap close to $750M US min.
Pharma's are not going to offer $1B U.S. on a $1 Can stock .
We meed a Mkt Cap of around $ 750M U.S. for them to pay a 30% premium.
YEs, looking at Semma & Sigilon we should be at least $1B U.S.
The Momentum is here now, Bioteck stocks are HOT.
The Bull Market is still intact, we need to move now before the Crash comes.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China